Literature DB >> 4832303

The bone marrow in aplastic anaemia: diagnostic and prognostic features.

B Frisch, S M Lewis.   

Abstract

Bone marrow preparations were examined from 80 patients with aplastic anaemia. The degree of cellularity varied greatly and in a third of the cases it was normal or even hypercellular at one site of aspiration. In the severely hypoplastic marrows lymphoid cells were predominant and this situation was associated with a worse prognosis. There was no correlation between marrow lymphoid cell content and blood lymphocyte count but there was an inverse relationship between blood lymphocyte count and marrow erythroblasts and a close direct relationship between the blood neutrophil count and marrow myeloid cell content. In all cases a proportion of the erythroblasts showed morphological abnormalities. These included especially megaloblastic changes and asynchrony of nuclear-cytoplasmic maturation. There were also binucleated cells, internuclear chromatin bridges, intercellular cytoplasmic connexions, nuclear degenerative changes, namely, blurred outlines, irregular shapes, budding and fragmentation, and atypical mitotic figures. These appearances illustrate the extent to which a qualitative defect of erythropoiesis occurs as part of the haematological pattern in aplastic anaemia, and in some cases dominates the bone marrow picture. Similar cytological features were found in all cases, including five patients with Fanconi's anaemia.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4832303      PMCID: PMC478077          DOI: 10.1136/jcp.27.3.231

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  Anomalies of blood group antigens and erythrocyte enzymes in two types of chronic refractory anaemia.

Authors:  B Dreyfus; C Sultan; H Rochant; C Salmon; P Mannoni; J P Cartron; P Boivin; C Galand
Journal:  Br J Haematol       Date:  1969-03       Impact factor: 6.998

2.  Studies on red cell aplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei.

Authors:  S B Krantz; V Kao
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

3.  Studies on red cell aplasia. II. Report of a second patient with an antibody to erythroblast nuclei and a remission after immunosuppressive therapy.

Authors:  S B Krantz; V Kao
Journal:  Blood       Date:  1969-07       Impact factor: 22.113

4.  Increased agglutinability by anti-i of red cells in sideroblastic and megaloblastic anaemia.

Authors:  A G Cooper; A V Hoffbrand; S M Worlledge
Journal:  Br J Haematol       Date:  1968-10       Impact factor: 6.998

5.  Lysis by anti-I in dyserythropoietic anaemias: role of increased uptake of antibody.

Authors:  S M Lewis; P Grammaticos; J V Dacie
Journal:  Br J Haematol       Date:  1970-04       Impact factor: 6.998

6.  Transformation of granulocytes to macrophages in bone marrow colonies in vitro.

Authors:  D Metcalf
Journal:  J Cell Physiol       Date:  1971-04       Impact factor: 6.384

7.  Aplastic anaemia: a disorder of the bone-marrow sinusoidal microcirculation rather than stem-cell failure?

Authors:  W H Knospe; W H Crosby
Journal:  Lancet       Date:  1971-01-02       Impact factor: 79.321

8.  Inhibition of erythropoiesis by a factor present in the plasma of patients with erythroblastopenia.

Authors:  J H Jepson; L Lowenstein
Journal:  Blood       Date:  1966-04       Impact factor: 22.113

9.  The aplastic anaemia--paroxysmal nocturnal haemoglobinuria syndrome.

Authors:  S M Lewis; J V Dacie
Journal:  Br J Haematol       Date:  1967-03       Impact factor: 6.998

10.  Aplastic anaemia, acute myeloblastic leukaemia, and oxymetholone.

Authors:  I W Delamore; C G Geary
Journal:  Br Med J       Date:  1971-06-26
View more
  7 in total

1.  Serial morphologic observation of bone marrow in aplastic anemia in children.

Authors:  Fumio Bessho; Shinsaku Imashuku; Shigeyoshi Hibi; Masahiro Tsuchida; Tatsutoshi Nakahata; Sumio Miyazaki; Seiji Kojima; Ichiro Tsukimoto; Nobuyuki Hamajima
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

2.  Editorial: Prognosis in aplastic anaemia.

Authors: 
Journal:  Br Med J       Date:  1975-10-18

3.  Morphological investigation on phenylhydrazine-induced erythropoiesis in the adult mouse liver.

Authors:  R E Ploemacher; P L van Soest
Journal:  Cell Tissue Res       Date:  1977-03-24       Impact factor: 5.249

4.  The value of prognostic indices in aplastic anaemia.

Authors:  D T Sleijfer; N H Mulder; H O Nieweg
Journal:  Blut       Date:  1981-02

5.  Prognosis in acquired aplastic anemia. An approach in the selection of patients for allogeneic bone marrow transplantation.

Authors:  K P Hellriegel; M Züger; R Gross
Journal:  Blut       Date:  1977-01

6.  Aplastic anaemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic, and prognostic features.

Authors:  I Fohlmeister; R Fischer; B Mödder; M Rister; H E Schaefer
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

7.  The prognostic value of p53 mutation in pediatric marrow hypoplasia.

Authors:  Hasnaa A Abo-Elwafa; Fadia M Attia; Alzahraa E A Sharaf
Journal:  Diagn Pathol       Date:  2011-06-30       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.